Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : All About Sun Microsystems -- Ignore unavailable to you. Want to Upgrade?

To: JC Jaros who wrote (25715)	1/4/2000 7:47:00 PM
From: High-Tech East	Read Replies (2) \| Respond to of 64865

Thanks, JC - good counsel. I completely agree with you about bio-techs. They are tough to figure and are very high risk. I think this one is special ... (1) I physically toured the company, met the CFO, and have read a lot about them, so I feel that I know a lot about them. (2) Their new product, the Abiomed/AbioCor total artificial heart will probably create a lot of shareholder value with the coming media and analyst coverage by itself (I think). (3) Whenever (or if) the FDA approves the AbioCor for clinical trials in humans, I think the stock price will quickly accelerate to a peak. I plan to sell a large percentage at that point. Once trials start, things could be very volatile, as I doubt that every transplant will be totally successful or trouble free. My wife Jan and I are very excited about it from both a medical and financial view. Although, we could wipe out a large portion of our SUNW profits that we have invested there. In terms of SUNW, I would not have sold it if I thought it would only drop 4 3/4 points. I don't know at what price I will start to rebuild a position. I do know that it feels strange to believe that SUNW will lead us to true wealth, and at the same time not own any right now. Ken Wilson